🇺🇸 FDA
Pipeline program

Humira 40 mg solution for injection in pre-filled syringe

18146

Phase 2 small_molecule active

Quick answer

Humira 40 mg solution for injection in pre-filled syringe for Inflammatory Bowel Disease (IBD) is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Inflammatory Bowel Disease (IBD)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials